HUMAN FERTILISATION & EMBRYOLOGY AUTHORITY THE SCIENTIFIC AND CLINICAL ADVANCES GROUP

Size: px
Start display at page:

Download "HUMAN FERTILISATION & EMBRYOLOGY AUTHORITY THE SCIENTIFIC AND CLINICAL ADVANCES GROUP"

Transcription

1 HUMAN FERTILISATION & EMBRYOLOGY AUTHORITY THE SCIENTIFIC AND CLINICAL ADVANCES GROUP EMBRYO TRANSFER REVIEW 1. Members are asked to consider the embryo transfer review paper SCAG (04/03)01. Issues to consider 2. Members are asked to consider the literature review and to consider the following issues: To consider the issue raised in this current brief review, in particular: The methodology to be used in monitoring the new two embryo policy, this includes the proposal that embryo transfers and pregnancy outcomes can be recorded through the Registry on the treatment forms. A report could possibly be made available to Members of SCAG towards the end of the year on the data collected. The evidence available for more than two embryos to be transferred in poor prognosis patients The impact that the new HFEA policy will have on clinics. The evidence for moving towards an elective one embryo transfer policy. Future work for SCAG. Christina Panton HFEA Executive April

2 HUMAN FERTILISATION & EMBRYOLOGY AUTHORITY THE SCIENTIFIC AND CLINICAL ADVANCES GROUP EMBRYO TRANSFER REVIEW 1. Background 1.1 Several European states now routinely limit embryo replacement to two embryos per cycle and others are also pushing for the reduction to single embryo transfers (Van Royen et al 1999). By contrast in the USA the replacement of five or even six embryos is allowed under certain circumstances (SART Guidelines, November 1999). Against this background of seriously conflicting views the HFEA decided in 2001 to re-examine its embryo replacement policy to see whether it remains appropriate. 1.2 The original embryo transfer policy amended in August 2001 stated: As a consequence of the review, the Authority has decided to revise its policy on embryo transfer, reducing the number of embryos to normally be transferred from three to two. In exceptional circumstances, a three egg or three embryo transfer may be performed. These exceptional circumstances will be case specific, (HFEA CH (08)01). 1.3 Technology in the field of ART has improved considerably in the 12 years since the HFE Act 1990 was passed. Live birth rates in IVF have increased from 14% per treatment cycle in 1991/2 to a national average of 21.8% in 2000/ However, more recent analysis of data submitted to the HFEA for the year April 2000/2001 indicates 109 sets of triplets (1.7%) and 1579 sets of twins (25%) born from cycles undertaken. The range of two embryo transfer cycles varied substantially between an excess of 80% elective transfer of 2 embryos (18 out of 64 centres) to less than 20% (4 clinics) regardless of age. One third of the centres (21/64) accounted for 53% of the live-born triplets and more than 50% of their transfers were 3 embryos (Braude 2003 unpublished). These figures reflect the unacceptably high rate of multiple pregnancy and the inconsistency in which centres have applied the exceptional circumstances provision. 1.5 The HFEA has recently announced, through it s launch of the 6 th edition of the Code of Practice, a revised policy for the number of embryos that should be transferred in any given treatment cycle as follows: To reduce the risk of multiple pregnancy, centres are expected to place no more than either two eggs or two embryos in a woman in any one cycle 2

3 1.6 This new policy has now been enshrined in the 6 th edition in paragraph The statement removes the notion that three embryos can be transferred in exceptional circumstances. However, a number of factors still remain that require careful consideration. As the following discussion supports, many patients will benefit from the two embryos transfer policy with little affect on their success rates, but their will be a small number of patients that may benefit from a higher number of embryos to be transferred. In addition, there is demonstrable inconsistency in the application of the 2 embryo transfer policy implemented in August 2001, as demonstrated by the Audit report attached in (Appendix A) where it is shown that in one particular centre over 90% of embryo transfers were three embryo transfers. 2. Professional Guidelines 2.1 This change in practice is reflected in the guidelines of both the British Fertility Society and the Royal College of Obstetrics and Gynaecology. 2.2 The BFS recommendations for good practice state that all possible efforts should be made to avoid multiple pregnancies. It then states that it should be usual practice to transfer a maximum of two embryos in each treatment cycle. 2.3 The RCOG s Evidence-Based Clinical Guidance No.6 states that a reduction in the number of multiple pregnancies resulting from assisted reproduction is of national importance and that every attempt should be made to avoid multiple births and particularly triplets, following IVF treatment. There follows a recommendation that a maximum of two embryos should be transferred in women under 40 years of age. 2.4 The Eshre Capri Workshop recommended either two or three embryos to be transferred depending on female age. However, in a more recent recommendation it was suggested that the number of embryos to be transferred should be limited to two (Eshre Workshop Group 2000) 3. International Laws and Policies relating to embryo transfer 3.1 The following international laws and policies have been noted: 3.2 Reproductive Technology (Code of Ethical Clinical Practice) Regulations of Southern Australia States that transferring more than three embryos or eggs in any one cycle is not permitted. 3.3 Select Committee on The Human Reproductive Technology Act 1991 Report (Western Australia) States that up to three embryos can be transferred in any one cycle., although an from Sandra Webb from the Western Australia Reproductive Technology Council indicates that the Act itself does not set a limit. Instead, practitioners must maintain the standards set by the Reproductive Technology Accreditation Committee. These encourage two, but may allow three or even four in exceptional circumstances. 3

4 3.4 Infertility Treatment Authority, Victoria, Australia, Conditions of Licence Allows more than four embryos to be transferred in exceptional circumstances, especially if the woman is over Guidelines of the German Medical Association Two embryo transfer recommended. 3.6 ESHRE Guidelines for Good Practice in IVF Laboratories Makes a general recommendation against transferring more than two embryos. 3.7 Netherlands Health Council s Report on IVF (1997) Normally no more than two and never more than three embryos are to be transferred at any one time. 3.8 Fertility Society of Australia Code of Practice for Centres using Assisted Reproductive Technology States that for women over 40, the low implantation rate makes it permissible to transfer even more than four embryos or oocytes. 4. Multiple Births 4.1 There is continuing concern about the high incidence of multiple births following IVF treatment. Many authors have confirmed that multiple births are an avoidable complication resulting in high perinatal morbidity and mortality (Petterson et al., 1993; FIVNAT 1995; Dunn and McFarlane., 1996) and significant financial (Callahan et al 1994; Mugford and Henderson 1995) and Psychological (Garel et al.,1997) consequences. 4.2 Infants born after IVF in Australia were more likely to require neonatal ventilator use than non-ivf infants, irrespective of whether they were born as a singleton or multiple pregnancies (Leslie et al 1992). They were more likely to utilise the resources of neonatal intensive care units, but less likely to visit GPs or other health workers during their first year of life (Leslie et al., 1998). The increased need for neonatal care has been attributed to the well known increased rate of preterm births and multiple births and multiple birth after IVF (Gissler et al 1995; Bergh et al 1999). 4.3 More recently, much attention has been given to the economic impact of multiple gestations (Elster 2000; Jones 2003 PhD thesis, unpublished data). 4.4 A study by Ericson et al., 2002 confirms and extends previously published observations that the main increased utilization of health care by IVF children occurs during the first period of life. This study shows that IVF children have an increased use of in patient care, not only in the neonatal period but for some years afterwards. The article concludes that by reducing the rate of twin births by using one embryo transfer a substantial saving in hospital cost could be achieved, which could then balance the extra number of embryo transfers needed in order to obtain a pregnancy. 4

5 5. Reduction of Multiple Births 5.1 The best way of reducing the number of multiple births is to reduce the number of embryos placed in a woman in the course of IVF treatment. It is also possible to reduce the incidence of multiple births by fetal reduction after implantation has occurred however the procedure is invasive and it is important to remember that embryo reduction may be accompanied by, long term psychological side effects. Embryo reduction should be regarded as a useful tool but not as a means to facilitate high order embryo transfers (Wennerholm et al., 2000). 5.2 The number of fetal reductions recorded in the National Statistics Series AB no 28, Abortion Statistics 2001 HMSO 2002(Appendix B) shows that for 2001 : 49 cases in all to women resident in Eng & Wales (of which 22 were carried out under Section 1(1)(d)[ that there is a substantial risk that if the child were born it would suffer from such physical or mental abnormalities as to be seriously handicapped] and the further 28 under [Section 1(1)(a) that the pregnancy has not exceeded its twenty-fourth week and that the continuance of the pregnancy would involve risk, greater than if the pregnancy were terminated, of injury to the physical or mental health of the pregnant woman or any existing children of her family] and [Section 1(1)(b) that the termination is necessary to prevent grave permanent injury to the physical or mental health of the pregnant woman]. 5.3 It is not recorded which of these pregnancies resulted from assisted conception. 5.4 Details of procedures are collected on the abortion notification form HSA4. This form must be submitted to the CMO within 14 days of the procedure. It is a criminal offence not to notify such a procedure under the Abortion Act 1967 as amended by section 37 of the HFEA Act There is no evidence to suggest significant under-reporting from centres (Appendix. 6. Two Embryo Transfer 6.1 In order to further reduce the multiple pregnancy rates especially triplet pregnancies, replacement of only 2 embryos has been advocated by many authors (Waterstone et al., 1991; Templeton and Morris 1998; Nijs et al 1993; Staessen et al. 1993; Vauthier 1994; Fujii 1998; Devreker1999; Dean 2000; Ernest Hung Yu Ng et al 2001). 6.2 Further to the studies mentioned above, Engmann et al 2001 conducted one of the first studies in a single centre in the UK that spanned a period both before and after the HFEA s policy of limiting the number of embryos transferred to three. 5

6 6.3 They argue that previous studies investigating factors associated with the probability of multiple birth, and examining how limiting the number of embryos transferred affects the probability of both birth and multiple births, have tended to be based on either relatively small data series (Nijs et al., 1993; Staesen et al., 1993; Bassl et al 1997; Elsner et al 1997) or on pooling of heterogenous data from several different clinics (Templeton and Morris, 1998; Schieve et al 1999). 6.4 This study examined trends over time, in the probability of birth (single or multiple) and the proportion of multiple births among deliveries, using data from a single centre in the UK between 1984 and 1997 which spanned periods pre and post HFEA legislation. Their study suggests that increasing the number of embryos transferred has little or no effect on the probability of birth, but merely increases the probability of multiple birth. The authors encourage a reduction in the number of embryos to be transferred. 6.5 Given that in a majority of the cases an embryo never reaches the uterine cavity in vivo at 48 72h, which is the case in the majority of IVF cycles today, recent studies by (Hernandez 2001;Hamberger & Hazekamp 2002) discuss the importance of optimisation of culture conditions. Optimising the culture conditions would permit a better selection of embryos and perhaps a more optimal timing for replacement. A number of specific problems related to IVF embryo transfer policy can be identified that require optimisation. These include; natural or stimulated cycle; fertilisation; culture of embryos; PGD; freezing of oocytes and embryos; embryo reduction; patient age. 7. Patient Age 7.1 Poor reproductive outcomes in older patients undergoing IVF embryo transfer with their own oocytes have been well documented (Van Blerkom et al., 1995; Grasie et al., 1997; Janny and Menezeo, 1996). However, high pregnancy rates have been reported in women of advanced reproductive age following the transfer of embryos obtained from oocytes from younger women (Navot et al 1994). This suggests that endometrial receptivity in some older patients may not be compromised and that their poor performance is largely due to poor quality oocytes and embryos. A study by Obasaju M et al 2001 confirms, as with other authors, that aneuploidy is the principal cause of the poor pregnancy prognosis observed in women of this age group. This study demonstrates that acceptable pregnancy rates can be obtained from the transfer of single chromosomally normal embryos in women over 40 years of age despite the high rate of aneuploidy detected. 7.2 A paper by Licciardi et al 2001 examined whether limiting the number of embryos transferred in an oocyte donation program can maintain acceptable pregnancy rates while reducing the overall risk of multiple birth. The model demonstrated that in good prognosis patients, the implantation and pregnancy rates were not compromised by limiting the number of embryos replaced. The article also argued that where the ASRM has recommended that the presence of frozen embryos be considered when determining the embryo transfer number in patients under 35 years, the authors were of the view that they did not observe a difference in pregnancy rate relative to 6

7 cryopreservation status and suggested that the decision to transfer fewer embryos be independent of that. 7.3 In light of the above discussion it is interesting to note that in the data provided by the HFEA to the EIM 2000 (Appendix C) that 931 three embryo transfers were carried out compared to 912 two embryo transfers for oocyte recipients in the higher age group of patients. 8. The move towards a single embryo transfer 8.1 In contradiction to Licciardi et al 2001 above, clinical data provided by Tiitinen et al., 2001 showed that elective single embryo transfer with a good cryopreservation programme results in very acceptable pregnancy rates with a low risk for twins in a selected patient group. 8.2 A more recent study (Sutter et al., 2002) has shown that more ART cycles are required to obtain the same number of children born following single embryo transfer compared to two embryo transfer. Single embryo transfer allows the avoidance of twins and thus diminishes pregnancy-related and neonatal care costs. The authors showed that two embryo transfer is more effective in terms of child per cycle rate, but single embryo transfer is as cost effective per child born. Twins originating from two embryo transfer increase the indirect and long tem costs of neonatal care; however these were not discussed in this paper.the real advantage of single embryo transfer is the avoidance of the very high long term costs resulting from the increased morbidity of twins after birth. 8.3 The decrease in the number of embryos transferred from two to one is feasible in at least one third of the population of patients, reducing the twin incidence to approximately half of its original incidence and maintaining a high overall pregnancy rate. The most suitable group of patients are young women in their first IVF/ICSI cycle (Martikainen et al., 2001; Gerris et al., 2002) Combining validated strict growth criteria of early cleaving embryos with a clinical profile of the twin prone patient as described by some authors (Strandell et al 2000) would be a most successful combination. 8.4 A Recommendation made by Eshre Campus Course Report 2001 states: A twin or higher order MP of 25% or more is not acceptable and must induce practitioners to elaborate an individualised embryo transfer strategy aiming to reduce this incidence to perhaps 10%. 8.5 Elective single embryo transfer should be recommended if at least 2 conditions are met. Patient is twin prone needs defining If a top quality embryo can be transferred what is the definition of a top quality embryo and how could this be made consistent amongst centres. 7

8 9. Discussion 9.1 Given the heterogeneity within IVF couples, many centres may consider the current limit of two embryos to be quite restrictive and impeding on clinical judgement. Many practitioners consider that individualisation of the number transferred according to different personal criteria is the best way to improve the chances of success for a given couple. Factors that should be considered are usually; age of woman, number of attempts, embryo quality and fertilisation rate. 9.2 Perhaps the biggest challenge persisting in the field of human ART is to identify the most developmentally competent embryos available so that fewer embryos of higher quality are transferred. Only then will the goal of maximising the pregnancy rate while minimising the risk of a high order multiple gestation be achieved. 9.3 Cohen et al., 2001 discusses the many explanations for the fact that no consensus can be reached on the strategies to avoid multiple pregnancies in ART; Teams in IVF are not always the same as the obstetrical ones and usually not the same teams as those that follow through the patients complications. The fact that triplets are not always an obstetrical problem even though it is always a psychological, economical and social complication. The fact that a twin pregnancy even though it is often less complicated than a triplet one, induces 42% of prematurity (55% are before 32 weeks) and more than 3% of twins die in utero or are neonatal deaths. This is not well known. The fact that women and couples are unaware of the difficulties of multiple pregnancies and births bring pressure on the doctors to replace a maximum number of embryos to increase their chances. The fact that IVF teams take in to account the financial factors of the couple and try to give them as maximum chance as they can on each attempt. The fact that not all teams have at their disposal a good cryopreservation program. 9.4 A strategy of elective transfer of two embryos would probably be largely acceptable if: A good selection of high quality embryos on day 3 would allow a high rate of transfer of one or two blastocysts. Good results of cryopreservation program were part of the agreement of an IVF centre. The singleton live birth rates were the principal outcome of ART reported by centres and registries, twins and triplets should be reported separately. Financial considerations could improve. Public or private insurers and patients could be informed that the limited costs of reimbursement of IVF/ICSI procedures will be regained by the prevention of large costs of children born from multiple pregnancies. 9.5 Finally, there is evidence to suggest a possible move towards an elective one embryo transfer. It is clear from the evidence available that this would be successful in certain 8

9 patient groups. The implementation of such a policy requires extensive counselling of the infertile couple, appropriate legislation and a strict selection criteria (Pinborg et., 2003). 10. Conclusion 10.1 This review would indicates that the current HFEA two embryo transfer policy is appropriate practice for good prognosis patients and in some cases selected patient groups would benefit from elective one embryo transfer. Such a policy would significantly reduce the multiple pregnancy rates in clinics without reducing the overall live birth rates It is important that the HFEA maintains a continuing monitoring process to ensure that this new policy is implemented correctly. The HFEA should use its extensive data base to monitor the implementation of the two embryo transfer policy and to provide an evidence base to support centres and the Authority when reviewing the live birth rates. This will ensure that centres maintain a consistent approach to this policy and maintain best practice. 11. Issues to consider: 11.1 Members are asked to consider the literature review and to consider the following issues: To consider the issue raised this current brief review, in particular: The methodology to be used in monitoring the new two embryo policy, this includes the proposal that embryo transfers and pregnancy outcomes can be recorded through the Registry on the treatment forms. A report could possibly be made available to Members of SCAG towards the end of the year on the data collected. The evidence available for more than two embryos to be transferred in poor prognosis patients The impact that the new HFEA policy will have on clinics. The evidence for moving towards an elective one embryo transfer policy. Future work for SCAG. Christina Panton HFEA Executive April

10 APPENDIX A Progress Report on the Audit (Data Register Project) (Presented as part of the above report to The Authority Meeting Held in February 2003) Transfers of 3 or more embryos We looked at 610 embryo transfers, of which 85 (14%) were 3-embryo transfers. In some cases (notably centres 068, 069, 032) reasons were not recorded for the 3- embryo transfer. We noted particularly high rates of 3-embryo transfer from the samples examined at the following centres: Centre Embryo transfers examined 3-embryo transfers % 3-embryo transfers % % % % 10

11 Licensed Fertility Treatment: Selective Terminations Lord Alton of Liverpool asked Her Majesty's Government: APPENDIX B How many pregnancies arising out of licensed fertility treatment have been selectively terminated in each of the past five years; at what stage of gestation was each pregnancy terminated; and on what ground of the Abortion Act 1967 (as amended) was each abortion performed.[hl2146] Baroness Andrews: Information on whether selective terminations of pregnancy were performed following licensed fertility treatment is not collected centrally as it is not a requirement of the Abortion Regulations Information is collected on gestation and grounds and is shown in the following table. Data are for all selective terminations performed in England and Wales in the past five years. 1 Apr 2003 : Column WA121 Number of selectively terminated pregnancies, by gestation and grounds under the Abortion Act 1967, as amended, in England and Wales, 1997 to 2001 Year Gestation in weeks Section 1(1)(a) Section 1(1)(b) Section 1(1)(c) Section 1(1)(d) 1997 under to to and over Total under to to and over Total under to to and over Total under to to and over Total under Total 11

12 9 to to and over Total Prepared by Department of Health, Statistics Division 3G. 1. Data for 2002 will be available later this year. 2. The grounds under the Act are as follows: Section 1(1)(a) that the pregnancy has not exceeded its twenty-fourth week and that the continuance of the pregnancy would involve risk, greater than if the pregnancy were terminated, of injury to the physical or mental health of the pregnant woman or any existing children of her family; or Section 1(1)(b) that the termination is necessary to prevent grave permanent injury to the physical or mental health of the pregnant woman; or Section 1(1)(c) that the continuance of the pregnancy would involve risk to the life of the pregnant woman, greater than if the pregnancy were terminated; or Section 1(1)(d) that there is a substantial risk that if the child were born it would suffer from such physical or mental abnormalities as to be seriously handicapped. 12

13 APPENDIX C European IVF Monitoring (EIM) 2000 Name of country United Kingdom (Please note that these figures have yet to be audited or verified by the HFEA) Name and full address of contact person. Richard Baranowski Human Fertilisation & Embryology Authority Paxton House 30 Artillery Lane London E1 7LS Telephone +44 (0) Fax +44 (0) richard.baranowski@hfea.gov.uk Please return prior to 1 st of april 2003 to ESHRE Central Office Van Aakenstraat 41 B-1850 Grimbergen, Belgium Tlf FAX bruno.vandeneede@eshre.com 13

14 European IVF monitoring (EIM) 2000 Module 0 Number and size of clinics IVF clinics (units) in the country Number Total number of clinics in the country 75 Total number of clinics reporting to the National Register 75 Size of the clinics. (Based on the total annual number of IVF, ICSI, FER and ED combined) Number of clinics < 100 cycles cycles cycles cycles 24 > cycles 7 14

15 15 SCAG(04/03)01

16 European IVF monitoring (EIM) 2000 Module 1 a IVF and ICSI fresh cycles Number of treatments and pregnancies IVF (n) ICSI (n) All (n) Initiated cycles Aspirations Transfers, all Transfer 1 embryo * ( all ) Transfer 2 embryos Transfer 3 embryos Transfer 4 or more embryos Pregnancies**, all * Indicate if possible the number of elective single embryo transfers after IVF and ICSI combined : Not possible * Indicate - if possible the number of elective dual embryos transfer after IVF and ICSI combined : Not possible ** Please use the WHO definition of clinical pregnancy: evidence of pregnancy by clinical or ultrasound parameters (ultrasound visualisation of a gestational sac). It includes ectopic pregnancy. Multiple gestational sacs in one patient are counted as one clinical pregnancy. 16

17 Currently, the HFEA makes use of only 1 index for clinical pregnancy - detection of fetal pulsation on ultrasound and so cannot supply the number of clinical pregnancies exactly as defined by WHO. 17

18 European IVF monitoring (EIM) 2000 Module 1 a Number of treatments and pregnancies FER. Frozen embryo (or 2 PN) replacements IVF (n) ICSI (n) All (n) Thawings Transfers, all Transfer of 1 embryo Transfers of 2 embryos Transfers of 3 embryos Transfers of 4 or more embryos Pregnancies, all Egg donations Donation cycles Transfers, all Transfer 1 embryo IVF (n) ICSI (n) All (n) Transfer 2 embryos Transfer 3 embryos

19 Transfer of 4 or more embryos Pregnancies, all

20 European IVF monitoring (EIM) 2000 Module 1 a. Preimplantation Genetic Diagnosis (PGD) Number of treatments, pregnancies and deliveries ( n ) Initiated cycles Aspirations Transfers Pregnancies Deliveries Not available Not available Not available Not available Not available 20

21 European IVF monitoring (EIM) Module 1b Female age Number of initiated cycles in specific age groups in relation to treatment. IVF ICSI EGG DONATION Age < Age Age Age Age > All women

22 European IVF monitoring (EIM) 2000 Module 1 c Complications to treatments and fetal reduction Complications with admission to hospital Number Hyperstimulation syndrome 376 Complications to oocyte retrieval (all) 120 Bleeding 6 Infection 0 Maternal death (documented) Not available Fetal reduction 82 22

23 European IVF monitoring 2000 Module 2ART deliveries resulting from treatments performed in 2000 IVF (n) ICSI (n) FER (n) Egg Donation (n) PGD (n) Clinical pregnancies (all) Not available Documented pregnancy losses (abortions and ectopic pregnancies) Not available Lost for follow-up Not available Singleton deliveries Not available Twin deliveries Not available Triplet deliveries Not available Quadruplet deliveries Not available All deliveries Not available 23

24 BIBLIOGRAPHY Paper considered: Bassil S. Predictive factors for multiple pregnancy in in-vitro fertilisation. J. Reproduct. Med 42, Bergh et al., Deliveries and children born after in-vitro fertilisation in Sweden ; a retrospective cohort study. Lancet 354, Braude P., The UK legislative experience: A model for other countries. (2003 Unpublished paper). Callahan T. L., et al., The economic impact of multiple gestation pregnancies and the contributin of assisted reproduction. N. Engl. J Med., 331, Cohen et al. How to avoid Multiple Pregnancies in Asssited Reproductive Technologies. Seminars in reproductive Medicine Vol 19 N0. No Dean NL et al., Impact of reducing the number of embryos transferred form three to two in women under the age of 35 who produced three or more high-qulaity embryos. Ferility & Sterility 74: Devreker F et al., Comparison of two elective transfer policies of two embryos to reduce multiple pregnancies without impairing pregnancy rates. Human Reproduction 1999; 14: Elsner C.W., Multiple pregnancy rate and embryo transfer number during in vitro fertilisation Am J Obstet. Gynecol. 177, Elster N. Less is more: the risks of multiple births. The Institute for Science, law, and Technology Working Group on Reproductive Technology. Fertility and Sterility Oct; 74(4): Ericson et al., Hospitalisation of infants born after IVF. Human Reproduction Vol 17, No. 4 pp , Ernest Hung Yu Ng et al 2001: Transfer of two embryos instead of three will not compromise pregnancy rate but will reduce multiple pregnancy rate in an assisted reproduction unit. J. Obstet. Gynaecol. Res Vol 23 No E. Van Royen, K. Mangelschots et al., Characterization of a top quality embryo, a step towards single-embryo transfer, Human Reproduction, vol.14 no.9, pp , 1999 Engmann et al. Trends in the incidence of births and multiple birthe and the factors that determine the probability of multiple birth after IVF treatment. Human Reproduction Vol 16 No. 12 pp , SART Guidelines, November A. Dunn & A. Macfarlane, Recent trends in the incidence of multiple births and associated mortality in England and Wales, Archives of Disease in Childhood 75, F10-F19, Ericson et al: Hosptal care utilization of infants born after IVF. Human Reproduction Vol 17. No.4 pp ,

25 ESHRE Capri Workshop Group, Multiple gestation pregnancy, Human Reproduction, vol.15 no.7 pp , 2000; ESHRE guidelines for good practice in IVF laboratories. Human Reproduction 15 (10):2241, FIVNAT evaluation. Contracept Fertil Sex 1996 Sep ;24(9);694-9 F. Olivennes, Double trouble: yes a twin pregnancy is an adverse outcome Human Reproduction vol 15 no 8 pp , Fuji s et al., Reducing multiple pregnancies by restricting the number of embryos transferred in two at the first embryo attempt. Human Reproduction 1998; 13: Garel M et al., Psychological consequences of having triplets; a 4 year follow-up study. Fertil. Steril., 67, Garside WT et al., Sequential abalysis of zona thickness during in vitro culture of humanzygotes: correlation with embryo quality, age and implantation. Molecular Reproduction and Development 47, Gerris J., et al. Elective single day 3 embryo transfer halves the twinning rate without decrease in the ongoing pregnancy rate of an IVF/ICSI programme. Vol. 17, No.10 pp , Gissler M., et al., In-vitro fertilisation pregnancies and perinatal health in Finland Human Reproduction , Hamberger L and Hazekamp J. Towards single embryo transfer in IVF. Journal of Reproductive Immunology 55(2002) Hernandez E.R., Avoiding multiple pregnancies: sailing uncharted seas. Human Reproduction Vol 16 No. 4 pp Janny L., Menezo YJR 1996 Maternal age effect on early human embryonic development and blastocyst formation. Molecular Reproduction and Development 45, Jones C. The Economic Implications of Embryo Overdose unpublished data. Leslie G.I et al., In-vitro fertilization and neonatal ventilator use in a teriary center. Med. J. Aust., 157, Leslie G. I et al., Infants conceived using in-vitro fertilization do not over utilize health care resources after the neonatal period. Human Reproduction., 13, , Licciardi et al., A two versus three-embryo transfer: the oocyte donation model. Fertility and Sterility Vol 75 No. 3 March Mugford, M and Henderson, J (1995) resource implications of multiple births. In ward H.R Whittle, M (eds) Multiple Births, RCOG,London UK, pp Navot D, et al., Age related decline in female fertility is not due to diminished capacity of the uterus to sustain embryo implantation. Fertility and Sterility 61., Nijs et al., Prevention of multiple pregnancies in an in vitro fertilization program Fertility and Sterility 1993; 59:

26 Petterson B et al., Cerebal palsy in multiple births in Western Australia. Am J. Med. Genet., 37, , Pinborg A et al. Attitudes of IVF/ICSI twin mothers towards twins and SET. Human Reproduction Vol 18 No Obasaju M et al. pregnancies from single normal embryo transfer in women older than 40 years. Vol2 No Reproductive BioMedicine Online webpaper 2000/061 on web 7 Mar 01. A. Templeton & J. Morris, Reducing the risk of multiple births by transfer of two embryos after in vitro fertilisation, The New England Journal of Medicine, vol 339 no 9, pp , 1998; M. Tasdemir, I. Tasdemir, et al, Two instead of three embryo transfer in in-vitro fertilization, Human Reproduction vol 10 no 8 pp , RCOG s Evidence-Based Clinical Guidance No.6 states C. Staessen, C. Janssenswillen, et al, Avoidance of triplet pregnancies by elective transfer of two good quality embryos, Human Reproduction vol 8 no 10 pp , L.A. Schieve, H.B. Peterson, et al, Live-Birth Rates and multiple-birth risk using in vitro fertilisation, JAMA, vol.282, no. 19 pp , November Racowsky C. High Rates of embryonic loss, Yet high incidence of multiple births in human ART: is this paradoxical? Theriogenology 57:87-96, T.J. Child & D.H. Barlow, Strategies to prevent multiple pregnancies in assisted conception programmes, Balliere s Clinical Obstetrics and Gynaecology, vol.12. No.1, pp , March Y. Hu, W.S. Maxson et al., Maximizing pregnancy rates and limiting higher-order multiple conceptions by determining the optimal number of embryos to transfer based on quality, Fertility and Sterility, vol.69, no.4, pp , T.O. Svendson, D. Jones et al., The incidence of multiple gestations after in vitro fertilisation is dependent on the number of embryos transferred and maternal age, Fertility and Sterility 65, pp , S. Senoz, A. Ben-Chetrit & R.F. Casper, An IVF Fallacy: Multiple pregnancy risk is lower for older women, Journal of Assisted Reproduction and Genetics, vol.14, no.4, pp , Sutter De P., et al., A health-economic decision-analytic model comparing double with single embryo transfer in IVF/ICSI. Vol.17, No.11 pp , Tiitinen A., et al., Elective single embryo transfer: the value of cryopreservation. Vol 16., No.6pp , 2001 Van Blerkom et al., ATP content of human oocytes and developmental potential and outcome after in vitro fertilization and embryo trabsfer. Human Reproduction 10, Vauthier-Bourzes D et al. How many embryos should be transferred in in-vitro fertilization? Fertility and Sterility 62: Waterstone J. et al., Elective transfer of two embryos. Lancet 1991; 337:

27 Wennerholm U.B., et al., Incidence of congenital malformations in children born after ICSI. Human Reproduction 15,

European IVF Monitoring (EIM) Year: 2013

European IVF Monitoring (EIM) Year: 2013 European IVF Monitoring (EIM) Year: 2013 Name of the country Poland Name and full address of the contact person. Anna Janicka, PhD Polish Society of Reproductive Medicine and Embryology Fertility and Sterility

More information

European IVF Monitoring (EIM) Year: 2012

European IVF Monitoring (EIM) Year: 2012 European IVF Monitoring (EIM) Year: 2012 Name of the country Poland Name and full address of the contact person. Professor Rafal Kurzawa, MD PhD Wojska Polskiego 103 Street 70-483 Szczecin Poland Telephone

More information

International Federation of Fertility Societies. Global Standards of Infertility Care

International Federation of Fertility Societies. Global Standards of Infertility Care International Federation of Fertility Societies Global Standards of Infertility Care Standard 8 Reducing the incidence of multiple pregnancy following treatment for infertility Name Version number Author

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright, 1998, by the Massachusetts Medical Society VOLUME 9 A UGUST 7, 1998 NUMBER 9 REDUCING THE RISK OF MULTIPLE BIRTHS BY TRANSFER OF TWO EMBRYOS AFTER IN VITRO

More information

The costs to the NHS of multiple births after IVF treatment in the UK

The costs to the NHS of multiple births after IVF treatment in the UK DOI: 10.1111/j.1471-0528.2005.00790.x www.blackwellpublishing.com/bjog Fertility and assisted reproduction The costs to the NHS of multiple births after IVF treatment in the UK William L Ledger, a Dilly

More information

SINCE THE GOAL OF IN VITRO FERtilization

SINCE THE GOAL OF IN VITRO FERtilization ORIGINAL CONTRIBUTION Live-Birth Rates and Multiple-Birth Risk Using In Vitro Fertilization Laura A. Schieve, PhD Herbert B. Peterson, MD Susan F. Meikle, MD Gary Jeng, PhD Isabella Danel, MD Nancy M.

More information

Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE

Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE Human Reproduction, Vol.1, No.1 pp. 1 21, 2009 doi:10.1093/humrep/dep035 Hum. Reprod. Advance Access published February 18, 2009 ORIGINAL ARTICLE ESHRE Assisted reproductive technology and intrauterine

More information

Number of oocytes and live births in IVF

Number of oocytes and live births in IVF Number of oocytes and live births in IVF Dr Sesh K Sunkara MD, MRCOG Royal Marsden Hospital, London Kings Healthcare Partners (Guy s & St Thomas NHS Foundation Trust), London, UK Background IVF results

More information

JAWDA Quarterly & Yearly Guidelines for Assisted Reproductive Technology Treatment (ART) Providers January 2019

JAWDA Quarterly & Yearly Guidelines for Assisted Reproductive Technology Treatment (ART) Providers January 2019 JAWDA Quarterly & Yearly Guidelines for Assisted Reproductive Technology Treatment (ART) Providers January 2019 Page 1 Table of Contents Executive Summary... 3 About this Guidance... 4 Glossary:... 5 ART

More information

Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification

Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification Aila Tiitinen Professor, reproductive medicine Head of IVF unit Helsinki University The outline

More information

Embryo Selection after IVF

Embryo Selection after IVF Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus

More information

Fertility treatment in trends and figures

Fertility treatment in trends and figures Fertility treatment in 2010 trends and figures Contents Page No: Foreword by the Chair of the HFEA 3 Summary 4 Section 1: Overview How many fertility clinics were there in the UK in 2010? 6 How many women

More information

Universal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D.

Universal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D. Universal Embryo Cryopreservation: Frozen versus Fresh Transfer Zaher Merhi, M.D. Disclosure: None Fewer complications with IVF 1.5% children in US are born through ART 1.1 million children since 2006

More information

Artigo original/original Article

Artigo original/original Article Artigo original/original Article Análise do registo português de procriação medicamente assistida: 1997-2005 A long-term analysis of the Portuguese assisted reproductive technologies data registry 1997-2005

More information

Articles Follow-up of children born after assisted reproductive technologies

Articles Follow-up of children born after assisted reproductive technologies RBMOnline - Vol 5. No 3. 317 322 Reproductive BioMedicine Online; www.rbmonline.com/article/669 on web 9 August 2002 Articles Follow-up of children born after assisted reproductive technologies Dr Michael

More information

Society for Assisted Reproductive Technology and American Society for Reproductive Medicine

Society for Assisted Reproductive Technology and American Society for Reproductive Medicine FERTILITY AND STERILITY VOL. 74, NO. 4, OCTOBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. ASRM/SART REGISTRY

More information

Human Fertilisation and Embryology Authority. Multiple Births after IVF in the United Kingdom

Human Fertilisation and Embryology Authority. Multiple Births after IVF in the United Kingdom response to the Human Fertilisation and Embryology Authority public consultation on Multiple Births after IVF in the United Kingdom July 2007 This document represents the British Fertility Society (BFS)

More information

Article Controlling the high order multiple birth rate: the European perspective

Article Controlling the high order multiple birth rate: the European perspective RBMOnline - Vol 6. No 3. 339 344 Reproductive BioMedicine Online; www.rbmonline.com/article/767 on web 3 January 2003 Article Controlling the high order multiple birth rate: the European perspective Dr

More information

Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services

Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services Reference No: Version: 2 Ratified by: EMSCGP006V2 EMSCG Date ratified:

More information

Policy statement. Commissioning of Fertility treatments

Policy statement. Commissioning of Fertility treatments Policy statement Commissioning of Fertility treatments NB: The policy relating to commissioning of fertility treatments is unchanged from the version approved by the CCG in March 2017. The clinical thresholds

More information

Female Patient Name: Social Security # Male Patient Name: Social Security #

Female Patient Name: Social Security # Male Patient Name: Social Security # Female Patient Name: Social Security # Male Patient Name: Social Security # THE CENTER FOR HUMAN REPRODUCTION (CHR) ILLINOIS/NEW YORK CITY * ASSISTED REPRODUCTIVE TECHNOLOGIES PROGRAM (A.R.T.) CRYOPRESERVATION

More information

St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16

St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16 St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16 1 Standard Operating Procedure St Helens CCG NHS Funded Treatment for Sub Fertility Policy Version 1 Implementation Date May 2015 Review

More information

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health. Prof.Duru Shah Founder President The PCOS Society (India) President Elect of the Indian Society for Assisted Reproduction (ISAR) Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive

More information

FIVNAT-CH Schweizerische Gesellschaft für Reproduktionsmedizin Société Suisse de Médecine de la Reproduction

FIVNAT-CH Schweizerische Gesellschaft für Reproduktionsmedizin Société Suisse de Médecine de la Reproduction SGRM / SSMR Schweizerische Gesellschaft für Reproduktionsmedizin FIVNAT-CH Schweizerische Gesellschaft für Reproduktionsmedizin Annual report 2013 Cycles 2012 Version 15.06.2014 Date of analysis 02.12.2013

More information

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1.

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1. *40675* 40675 MR-838 (9-2017) WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1. I, and (Print Patient s name) (Print

More information

FERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida

FERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida FERTILITY PRESERVATION Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida 1 2 3 4 Oocyte Cryopreservation Experimental option Offer to single cancer

More information

Your consent to donating your eggs

Your consent to donating your eggs HFEA WD form (Gender-neutral version) Your consent to donating your eggs About this form This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator

More information

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER *40639* 40639 WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IVF WITH EMBRYO TRANSFER I have requested treatment by the physicians and (Print Patient s name) staff of the Women & Infants Fertility

More information

Abstract. Introduction. Materials and methods. Patients and methods

Abstract. Introduction. Materials and methods. Patients and methods RBMOnline - Vol 8. No 3. 344-348 Reproductive BioMedicine Online; www.rbmonline.com/article/1178 on web 20 January 2004 Article Cumulative live birth rates after transfer of cryopreserved ICSI embryos

More information

Dr Guy Gudex. Gynaecologist and Fertility Specialist Repromed. 9:05-9:30 Advances in Assisted Reproduction What s New?

Dr Guy Gudex. Gynaecologist and Fertility Specialist Repromed. 9:05-9:30 Advances in Assisted Reproduction What s New? Dr Guy Gudex Gynaecologist and Fertility Specialist Repromed 9:05-9:30 Advances in Assisted Reproduction What s New? Rotorua GP CME June 2016 Advances in Assisted Reproduction-What s new? Dr Guy Gudex

More information

NICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic

NICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic NICE fertility guidelines Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic About the LWC 4 centres around the UK London Cardiff Swansea Darlington The largest sperm bank in

More information

Single embryo transfer: a mini-review

Single embryo transfer: a mini-review Human Reproduction Vol.20, No.2 pp. 323 327, 2005 Advance Access publication March 3, 2005 doi:10.1093/humrep/deh744 Single embryo transfer: a mini-review Christina Bergh Department of Obstetrics and Gynaecology,

More information

Fertility treatment in trends and figures

Fertility treatment in trends and figures Fertility treatment in 2011 trends and figures Contents Page No: Chair s foreword 3 Summary 4 Background 5 Frequently asked questions 7 Section 1: Overview How many fertility clinics were there in the

More information

Clinical Policy Committee

Clinical Policy Committee Northern, Eastern and Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group Clinical Policy Committee Commissioning policy: Assisted Conception Fertility treatments

More information

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR THAWING AND TRANSFER OF CRYOPRESERVED EMBRYOS. I and

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR THAWING AND TRANSFER OF CRYOPRESERVED EMBRYOS. I and *40668* 40668 WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR THAWING AND TRANSFER OF CRYOPRESERVED EMBRYOS FOR inpatients: affix patient label OR I and (Print Patient s name) (Print Partner

More information

15. Procuring, processing and transporting gametes and

15. Procuring, processing and transporting gametes and 15. Procuring, processing and transporting gametes and embryos Version 6.0 On this page: : Extracts from the HFE Act Directions HFEA guidance: Documented procedures: general Patient selection and procurement

More information

North Staffordshire Clinical Commissioning Group. Infertility and Assisted Reproduction Commissioning Policy and Eligibility Criteria

North Staffordshire Clinical Commissioning Group. Infertility and Assisted Reproduction Commissioning Policy and Eligibility Criteria North Staffordshire Clinical Commissioning Group Infertility and Assisted Reproduction Commissioning Policy and Eligibility Criteria Policy Infertility and Assisted Reproduction Commissioning Policy and

More information

Abstract. Introduction. RBMOnline - Vol 10. No Reproductive BioMedicine Online; on web 4 February 2005

Abstract. Introduction. RBMOnline - Vol 10. No Reproductive BioMedicine Online;  on web 4 February 2005 RBMOnline - Vol 10. No 4. 2005 436 441 Reproductive BioMedicine Online; www.rbmonline.com/article/1641 on web 4 February 2005 Ethics, legal, social, counselling Belgian legislation and the effect of elective

More information

NHS FUNDED TREATMENT FOR SUBFERTILITY. ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs

NHS FUNDED TREATMENT FOR SUBFERTILITY. ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs CONTENTS Page 1. INTRODUCTION 2 2. GENERAL PRINCIPLES 2 3. DEFINITION OF SUBFERTILITY AND TIMING OF ACCESS TO

More information

DRAFT Policy for the Provision of NHS funded Gamete Retrieval and Cryopreservation for the Preservation of Fertility

DRAFT Policy for the Provision of NHS funded Gamete Retrieval and Cryopreservation for the Preservation of Fertility NHS Birmingham and Solihull Clinical Commissioning Group NHS Sandwell and West Birmingham Clinical Commissioning Group DRAFT Policy for the Provision of NHS funded Gamete Retrieval and Cryopreservation

More information

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr. Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art

More information

Preimplantation Genetic Diagnosis (PGD) in Western Australia

Preimplantation Genetic Diagnosis (PGD) in Western Australia Preimplantation Genetic Diagnosis (PGD) in Western Australia Human somatic cells have 46 chromosomes each, made up of the 23 chromosomes provided by the egg and the sperm cell from each parent. Each chromosome

More information

D D M M Y Y D D M M Y Y. For clinic use only (optional) MD PNT only (gender-neutral): version 1; 3 April 2017

D D M M Y Y D D M M Y Y. For clinic use only (optional) MD PNT only (gender-neutral): version 1; 3 April 2017 This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator of fertility treatment and human embryo research. For more information about us, visit www.hfea.gov.uk.

More information

ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE

ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE Version 1.0 Page 1 of 11 MARCH 2014 POLICY DOCUMENT VERSION CONTROL CERTIFICATE TITLE Title: Assisted Conception

More information

Trends in Egg Donation. Vitaly A. Kushnir MD Center for Human Reproduction

Trends in Egg Donation. Vitaly A. Kushnir MD Center for Human Reproduction Trends in Egg Donation Vitaly A. Kushnir MD Center for Human Reproduction Disclosures No relevant financial relationships to disclose CHR views the commercial trade in human oocytes with considerable ethical

More information

Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial

Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial FULL PROJECT TITLE: Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial (STimulation Resulting in Embryonic Aneuploidy using Menopur (STREAM)

More information

Couples Information Leaflet

Couples Information Leaflet Couples Information Leaflet This project was funded by the National Institute for Health Research, Health Technology Assessment Programme (project number 13/115/82) You are due to undergo in vitro fertilisation

More information

Fill in this form if you are donating eggs and/or embryos created with your eggs for use in another person s mitochondrial donation

Fill in this form if you are donating eggs and/or embryos created with your eggs for use in another person s mitochondrial donation This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator of fertility treatment and human embryo research. For more information about us, visit www.hfea.gov.uk.

More information

Louise Brown born First IVF baby Born to Lesley Brown, bilateral tubal blockage Natural cycle, single egg fertilization

Louise Brown born First IVF baby Born to Lesley Brown, bilateral tubal blockage Natural cycle, single egg fertilization Louise Brown born First IVF baby Born to Lesley Brown, bilateral tubal blockage Natural cycle, single egg fertilization IVF 1878 - first reported attempts at IVF 1959 - IVF births in rabbits in USA 1968

More information

The impact of an assisted conception unit on the workload of a general gynaecology unit

The impact of an assisted conception unit on the workload of a general gynaecology unit BJOG: an International Journal of Obstetrics and Gynaecology February 2002, Vol. 109, pp. 207 211 The impact of an assisted conception unit on the workload of a general gynaecology unit Joanne McManus*,

More information

Clinical Policy Committee

Clinical Policy Committee Clinical Policy Committee Commissioning policy: Assisted Conception Fertility assessment and investigations are commissioned where: A woman is of reproductive age and has not conceived after one (1) year

More information

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2. COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.3 2017 Agreed at Cannock Chase CCG Signature: Designation: Chair of

More information

Women s consent to treatment and storage form (IVF and ICSI)

Women s consent to treatment and storage form (IVF and ICSI) Women s consent to treatment and storage form (IVF and ICSI) HFEA WT form About this form This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator

More information

Your consent to your sperm and embryos being used in treatment and/or stored (IVF and ICSI)

Your consent to your sperm and embryos being used in treatment and/or stored (IVF and ICSI) HFEA MT form (Gender-neutral version) Your consent to your sperm and embryos being used in treatment and/or stored (IVF and ICSI) About this form This form is produced by the Human Fertilisation and Embryology

More information

Dr Manuela Toledo - Procedures in ART -

Dr Manuela Toledo - Procedures in ART - Dr Manuela Toledo - Procedures in ART - Fertility Specialist MBBS FRANZCOG MMed CREI Specialities: IVF & infertility Fertility preservation Consulting Locations East Melbourne Planning a pregnancy - Folic

More information

IVF Health Risk 503,000 Hit in Google in 0.2 seconds

IVF Health Risk 503,000 Hit in Google in 0.2 seconds Assisted Reproductive Technologies and Perinatal Morbidity: Interrogating the Association Kurt Barnhart, M.D., MSCE. William Shippen Jr Professor of Obstetrics and Gynecology and Epidemiology Perelman

More information

HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY. CONTENTS Page

HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY. CONTENTS Page HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY CONTENTS Page 1. INTRODUCTION 2 2. GENERAL PRINCIPLES 2 3. DEFINITION OF SUBFERTILITY AND TIMING OF ACCESS TO TREATMENT 3 4. DEFINITION

More information

Births following fertility treatment in the GUI infant cohort. Aisling Murray Growing Up in Ireland, ESRI

Births following fertility treatment in the GUI infant cohort.  Aisling Murray Growing Up in Ireland, ESRI Births following fertility treatment in the GUI infant cohort www.growingup.ie Aisling Murray Growing Up in Ireland, ESRI About GUI Two cohorts: birth (9 months) and middle childhood (9 years) Current

More information

WHAT IS A PATIENT CARE ADVOCATE?

WHAT IS A PATIENT CARE ADVOCATE? WHAT IS A PATIENT CARE ADVOCATE? Fertility treatments can be overwhelming. As a member, you have unlimited access to a dedicated Patient Care Advocate (PCA), who acts as your expert resource for discussing

More information

Counseling for Potential Clients of RT Services

Counseling for Potential Clients of RT Services Assisted Reproductive Technology Unit Department of Obstetrics and Gynaecology The Chinese University of Hong Kong The Prince of Wales Hospital Counseling for Potential Clients of RT Services Husband s

More information

Regulating mitochondrial donation: seeking expert views. Background document

Regulating mitochondrial donation: seeking expert views. Background document Regulating mitochondrial donation: seeking expert views Background document June 2015 Contents Introduction 3 What we need from you 3 Licensing mitochondrial donation 4 Licensing the clinic to undertake

More information

Increase your chance of IVF Success. PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0)

Increase your chance of IVF Success. PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0) Increase your chance of IVF Success PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0) What is PGT-A? PGT-A, or Preimplantation Genetic Testing for Aneuploidy (PGS 2.0), is a type of genomic

More information

Health Scrutiny Panel 6 February 2014

Health Scrutiny Panel 6 February 2014 Agenda Item No: 5 Health Scrutiny Panel 6 February 2014 Report title Infertility Policy Review Wolverhampton Clinical Commissioning Group Cabinet member with lead responsibility Wards affected Accountable

More information

Overview. In Vitro Fertilization: a Success Story

Overview. In Vitro Fertilization: a Success Story Does IVF cause adverse perinatal outcomes? Paolo Rinaudo *, MD PhD Rebecca A. Jackson %, MD Departments of Ob/Gyn & *Center for Reproductive Sciences & % Epi/Biostats University of California, San Francisco

More information

Fertility Policy. December Introduction

Fertility Policy. December Introduction Fertility Policy December 2015 Introduction Camden Clinical Commissioning Group (CCG) is responsible for commissioning a range of health services including hospital, mental health and community services

More information

Leicester City, East Leicestershire and Rutland & West Leicestershire Collaborative Commissioning Policy Gamete/Embryo cryopreservation

Leicester City, East Leicestershire and Rutland & West Leicestershire Collaborative Commissioning Policy Gamete/Embryo cryopreservation Leicester City Clinical Commissioning Group West Leicestershire Clinical Commissioning Group East Leicestershire and Rutland Clinical Commissioning Group Leicester City, East Leicestershire and Rutland

More information

Your consent to the storage of your eggs or sperm

Your consent to the storage of your eggs or sperm Your consent to the storage of your eggs or sperm HFEA GS form About this form This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator of fertility

More information

Scientifically advanced. Personally accessible.

Scientifically advanced. Personally accessible. Scientifically advanced. Personally accessible. EmbryVu. Advanced preimplantation genetic screening that can help you find the path to pregnancy. The power to decide When you are going through treatment

More information

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES Version number V2.3 Responsible individual Author(s) Barry Weaver Trish

More information

Recommended Interim Policy Statement 150: Assisted Conception Services

Recommended Interim Policy Statement 150: Assisted Conception Services Southampton City Clinical Commissioning Group (CCG) took on commissioning responsibility for Assisted Conception Services from 1 April 2013 for its population and agreed to adopt the interim policy recommendations

More information

Egg Freezing for. Your Future. Specialists in Reproductive Medicine & Surgery, P.A.

Egg Freezing for. Your Future. Specialists in Reproductive Medicine & Surgery, P.A. Egg Freezing for Your Future Specialists in Reproductive Medicine & Surgery, P.A. www.dreamababy.com Egg freezing can be a game changer for women 40 years of age and younger. It has tremendous potential

More information

IVF. NHS North West London CCGs

IVF. NHS North West London CCGs IVF NHS North West London CCGs Commissioning Policy for In Vitro Fertilisation (IVF)/ Intracytoplasmic Sperm Injection (ICSI) within tertiary Infertility Services Adopted by NWL CCGs to be effective from

More information

Fertility Services Commissioning Policy (Level 3)

Fertility Services Commissioning Policy (Level 3) Fertility Services Commissioning Policy (Level 3) Author: Karin Bryant (Norwich CCG) has coordinated the refresh of policy Version No: V54 Policy Effective from: TBC Review Date: TBC This policy replaces

More information

Pre-Implantation Genetic Diagnosis. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN

Pre-Implantation Genetic Diagnosis. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN Pre-Implantation Genetic Diagnosis Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN Our Clinical Vignette A young couple in the mid-to-late twenties presents to your clinic to discuss having children. The

More information

INDICATIONS OF IVF/ICSI

INDICATIONS OF IVF/ICSI PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian

More information

Analysis of factors affecting embryo implantation

Analysis of factors affecting embryo implantation Analysis of factors affecting embryo implantation Andrew L.Speirst, H.W.G.Baker and Nusratudin Abdullah The Royal Women's Hospital, Melbourne, Australia ITo whom correspondence should be addressed Introduction

More information

Recent Developments in Infertility Treatment

Recent Developments in Infertility Treatment Recent Developments in Infertility Treatment John T. Queenan Jr., MD Professor, Dept. Of Ob/Gyn University of Rochester Medical Center Rochester, NY Disclosures I don t have financial interest or other

More information

Clinical outcomes among recipients of donated eggs: an analysis of the U.S. national experience,

Clinical outcomes among recipients of donated eggs: an analysis of the U.S. national experience, FERTILITY AND STERILITY VOL. 78, NO. 5, NOVEMBER 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Clinical outcomes

More information

Pre-Implantation Genetic Diagnosis. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN

Pre-Implantation Genetic Diagnosis. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN Pre-Implantation Genetic Diagnosis Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN Our Clinical Vignette A young couple in the mid-to-late twenties presents to your clinic to discuss having children. The

More information

Assisted Reproductive Technologies

Assisted Reproductive Technologies Assisted Reproductive Technologies ADDENDUM TO THE STEP REPORT August, 26 Submitted to: The Alberta Health Technologies Decision Process Research & Innovation Branch Strategic Planning & Policy Development

More information

Risk factors for monozygotic twinning in IVF: a multicenter, cohort study

Risk factors for monozygotic twinning in IVF: a multicenter, cohort study Risk factors for monozygotic twinning in IVF: a multicenter, cohort study New England Fertility Society May 6 th, 2017. Denis A. Vaughan Nothing to disclose Disclosures Objectives Background on monozygotic

More information

How effective is egg freezing as a preventative treatment for young women in securing their ability to reproduce later in life?

How effective is egg freezing as a preventative treatment for young women in securing their ability to reproduce later in life? How effective is egg freezing as a preventative treatment for young women in securing their ability to reproduce later in life? Vitaly A. Kushnir MD Center for Human Reproduction New York City Milestones

More information

Men s consent to the use and storage of sperm or embryos for surrogacy

Men s consent to the use and storage of sperm or embryos for surrogacy HFEA MSG form Men s consent to the use and storage of sperm or embryos for surrogacy About this form This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent

More information

Assisted Reproductive Technology National Summary Report Belgium 2015

Assisted Reproductive Technology National Summary Report Belgium 2015 Assisted Reproductive Technology National Summary Report Belgium 2015 College van Geneesheren Reproductieve Geneeskunde Collège de Médecins Médecine de la Reproduction College of Physicians Reproductive

More information

The facts about egg freezing

The facts about egg freezing The facts about egg freezing 1800 111 483 qfg.com.au Who might benefit from egg freezing? Age-related infertility in women is one of the most common issues presented to fertility specialists each day when

More information

Sperm Donation - Information for Donors

Sperm Donation - Information for Donors Sperm Donation - Information for Donors The donation of sperm to help someone to have a child is one of the most generous gifts anyone can give. Many donors feel a sense of pride, knowing the joy they

More information

MST and PNT allow eggs or embryos to be created for you containing your and your partner s nuclear genetic material D D M M Y Y D D M M Y Y

MST and PNT allow eggs or embryos to be created for you containing your and your partner s nuclear genetic material D D M M Y Y D D M M Y Y This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator of fertility treatment and human embryo research. For more information about us, visit www.hfea.gov.uk.

More information

Blackpool CCG. Policies for the Commissioning of Healthcare. Assisted Conception

Blackpool CCG. Policies for the Commissioning of Healthcare. Assisted Conception 1 Introduction Blackpool CCG Policies for the Commissioning of Healthcare Assisted Conception 1.1 This policy describes circumstances in which NHS Blackpool Clinical Commissioning Group (CCG) will fund

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Sandin S, Nygren K-G, Iliadou A, Hultman C, Reichenberg. Autism and Mental Retardation Among Offspring Born After In Vitro Fertilization. JAMA. doi:10.1001/jama.2013.7222.

More information

Women s consent to the use and storage of eggs or embryos for surrogacy

Women s consent to the use and storage of eggs or embryos for surrogacy Women s consent to the use and storage of eggs or embryos for surrogacy HFEA WSG form About this form This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent

More information

Directions given under the Human Fertilisation and Embryology Act 1990 as amended. Ref: 0006 Version: 4

Directions given under the Human Fertilisation and Embryology Act 1990 as amended. Ref: 0006 Version: 4 Directions given under the Human Fertilisation and Embryology Act 1990 as amended Import and export of gametes and embryo Ref: 0006 Version: 4 These Directions are: GENERAL DIRECTIONS Sections of the Act

More information

Fertility treatment and referral criteria for tertiary level assisted conception

Fertility treatment and referral criteria for tertiary level assisted conception Fertility treatment and referral criteria for tertiary level assisted conception Version Number Name of Originator/Author Cross Reference V2 East of England Consortium Commissioning Policy for Fertility

More information

Information about The Storage of Sperm, Eggs and Embryos before starting Chemo or Radiotherapy Treatment

Information about The Storage of Sperm, Eggs and Embryos before starting Chemo or Radiotherapy Treatment Information about The Storage of Sperm, Eggs and Embryos before starting Chemo or Radiotherapy Treatment Assisted Conception Services Glasgow Royal Infirmary 84 Castle Street Glasgow G4 0SF Telephone:

More information

T39: Fertility Policy Checklist

T39: Fertility Policy Checklist Patient Name: Address: Date of Birth: NHS Number: Consultant/Service to whom referral will be made: Institution Lifestyle Information Latest BMI: Latest BP: Smoking Status: Has the patient been referred

More information

UvA-DARE (Digital Academic Repository)

UvA-DARE (Digital Academic Repository) UvA-DARE (Digital Academic Repository) Clinical effectiveness of elective single versus double embryo transfer: meta-analysis of individual patient data from randomised trials McLernon, D.J.; Harrild,

More information

The preventative role of preimplantation genetic diagnosis?

The preventative role of preimplantation genetic diagnosis? The preventative role of preimplantation genetic diagnosis? Alison Lashwood Consultant Genetic Counsellor & Clinical Lead in PGD PGDGenetics@gstt.nhs.uk www.pgd.org.uk Where it all starts.. Kay & John

More information

Haringey CCG Fertility Policy April 2014

Haringey CCG Fertility Policy April 2014 Haringey CCG Fertility Policy April 2014 1 SUMMARY This policy describes the clinical pathways and entry criteria for Haringey patients wishing to access NHS funded fertility treatment. 2 RESPONSIBLE PERSON:

More information

Fertility treatment and referral criteria for tertiary level assisted conception

Fertility treatment and referral criteria for tertiary level assisted conception Fertility treatment and referral criteria for tertiary level assisted conception Version Number 2.0 Ratified by HVCCG Exec Team Date Ratified 9 th November 2017 Name of Originator/Author Dr Raj Nagaraj

More information

Fertility Services Commissioning Policy

Fertility Services Commissioning Policy Fertility Services Commissioning Policy NEE CCG Policy Reference: Where patients have commenced treatment in any cycle prior to this version becoming effective, they are subject to the eligibility criteria

More information